WFA
GBIO

Wipfli Financial Advisors’s Generation Bio GBIO Stock Holding History

Wipfli Financial Advisors’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$1K Buy
+15
New +$938 ﹤0.01% 2420

Other funds holding GBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wipfli Financial Advisors's GBIO Position: Q3 2022 in Review

Wipfli Financial Advisors opened a new position in Generation Bio (GBIO) in Q3 2022: 15 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #2420 among its holdings.

111 funds tracked by Wall St. Rank hold GBIO as of Q3 2022.

  • Wipfli Financial Advisors held 15 shares of Generation Bio worth $1K as of Q3 2022.
  • Generation Bio was a new Wipfli Financial Advisors position in Q3 2022.
  • Generation Bio made up ﹤0.01% of Wipfli Financial Advisors's portfolio in Q3 2022, its #2420 holding.
  • 111 funds tracked by Wall St. Rank held Generation Bio as of Q3 2022.

Based on Wipfli Financial Advisors's 13F filing for Q3 2022, filed 26 Oct 2022.